Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,252.20
Bid: 1,253.20
Ask: 1,253.60
Change: 9.20 (0.74%)
Spread: 0.40 (0.03%)
Open: 1,248.00
High: 1,255.60
Low: 1,221.60
Yest. Close: 1,243.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Sunday newspaper round-up: Vouchers, Grocers, Boohoo

(Sharecast News) - Radical plans to give all adults £500 and children £250 in vouchers to spend in sectors of the economy worst hit by the Covid-19 crisis are being considered by the Treasury. The proposals, drawn up by the Resolution Foundation think tank, which has had recent talks with the Treasury about its ideas, are aimed at kickstarting economic recovery by triggering a highly targeted surge in spending. Under the plans the vouchers could only be spent in certain sectors, such as hospitality and "face to face" retail, as opposed to online. - Guardian

5 Jul 20 15:59

PRESS: GlaxoSmithKline And Sanofi Near GBP500 Million UK Vaccine Deal

PRESS: GlaxoSmithKline And Sanofi Near GBP500 Million UK Vaccine Deal

5 Jul 20 14:51

UPDATE 1-Britain nears 500 million stg deal for Sanofi/GSK COVID-19 vaccine - Sunday Times

(Adds responses from UK government, GSK)LONDON, July 5 (Reuters) - Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Tim...

5 Jul 20 12:12

UPDATE 2-Britain nears $625 mln Sanofi/GSK COVID-19 vaccine deal -report

(Adds detail, context, background)By Alistair SmoutLONDON, July 5 (Reuters) - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine, the Sunday Times...

5 Jul 20 12:12

Britain nears 500 million stg supply deal for Sanofi/GSK COVID-19 vaccine - Sunday Times

LONDON, July 5 (Reuters) - Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.The newspaper said that Brit...

5 Jul 20 07:33

GSK says within weeks of resubmitting HIV injection Cabenuva

FRANKFURT, July 2 (Reuters) - GlaxoSmithKline's HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva to U.S. drug regulators, ViiV's head of research said on Thursday.ViiV executive Kimbe...

2 Jul 20 14:45

Inovio Pharmaceuticals's Covid-19 vaccine triggers immune response

(Sharecast News) - Inovio Pharmaceuticals's experimental vaccine against the novel coronavirus was found to be safe in an early stage clinical trial and successfully induced an immune response in the majority of participants in the test.

30 Jun 20 18:34

Single course of Covid-19 treatment to cost $2,340 per patient - Gilead

(Sharecast News) - Gilead Sciences has announced it will charge developed countries $390 a vial for remdesivir, its antiviral drug currently being investigated for use in Covid-19 patients.

29 Jun 20 12:00

TOP NEWS: GlaxoSmithKline Gets First Approval For Duvroq In Japan

TOP NEWS: GlaxoSmithKline Gets First Approval For Duvroq In Japan

29 Jun 20 09:03

GlaxoSmithKline clears regulatory hurdle in Japan for 'Duvroq'

(Sharecast News) - GlaxoSmithKline announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare in that country on Monday, for 'Duvroq', or daprodustat tablets.

29 Jun 20 08:28

LIVE MARKETS-Summer 2020 like

* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...

22 Jun 20 14:40

LIVE MARKETS-It's greener on the other side of the ESG fence

* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...

22 Jun 20 14:12

LIVE MARKETS-Hedge it with Tech!

* Wobbly session* STOXX now slightly down* U.S. futures still up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves ...

22 Jun 20 13:28

Antibody levels of Covid-19 patients decline quickly, small study shows

(Sharecast News) - Levels of antibodies in people who have suffered Covid-19 reportedly falls sharply in the two to three months following their infection, a study showed, although the implications for patient immunity were unclear.

22 Jun 20 12:54

LIVE MARKETS-Virus is scary, but it's not

* STOXX erases early losses* U.S. futures firmly up* Wirecard plunges again Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@...

22 Jun 20 11:09

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.